Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry

Document Type

Article

Publication Date

7-1-2016

Publication Title

The Journal of invasive cardiology

Abstract

BACKGROUND: Administration of a large amount of contrast volume during chronic total occlusion (CTO) percutaneous coronary intervention (PCI) may lead to contrast-induced nephropathy.

METHODS: We examined the association of clinical, angiographic and procedural variables with contrast volume administered during 1330 CTO-PCI procedures performed at 12 experienced United States centers.

RESULTS: Technical and procedural success was 90% and 88%, respectively, and mean contrast volume was 289 ± 138 mL. Approximately 33% of patients received >320 mL of contrast (high contrast utilization group). On univariable analysis, male gender (P=.01), smoking (P=.01), prior coronary artery bypass graft surgery (P=.04), moderate or severe calcification (P=.01), moderate or severe tortuosity (P=.04), proximal cap ambiguity (P=.01), distal cap at a bifurcation (P

CONCLUSIONS: Several baseline clinical, angiographic, and procedural characteristics are associated with higher contrast volume administration during CTO-PCI.

Medical Subject Headings

Aged; Contrast Media; Coronary Angiography; Coronary Occlusion; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intraoperative Care; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Registries; United States

PubMed ID

27342206

Volume

28

Issue

7

First Page

288

Last Page

294

Find It @ Sladen

Share

COinS